Gsk Share Discussion Threads

[ny boy] 30/11/2018 18:49

Defensive plays attractive in this market, I see no reason to sell.

[abdullla] 30/11/2018 18:28

Crown Laboratories Acquires Some Consumer Healthcare Brands From GlaxoSmithKlineSource: Dow Jones News

[abdullla] 30/11/2018 16:55

Strange happenings after the close.

[abdullla] 30/11/2018 16:50

Surprise closing auction share price up 24p,good job who did not sell.

[tradermichael] 30/11/2018 15:46

Decided to hold a little longer. This rise has impressed, so long as it maintains >1600p for now.

[montyhedge] 30/11/2018 12:46

No deal pound falls 10%, dollar earners score, GSK 1780p.

[tradermichael] 30/11/2018 12:42

Yes! Still have a large number at 1700p.

The aim is to buy/sell/buy/sell the lower priced ones on the way up to >1700p while reinvesting the profits and collecting the dividends (and reinvesting them)

[sicker] 30/11/2018 12:25

TM, and some of the remaining at £17 ;-)

[glasgow13] 30/11/2018 10:35

Thanks for reply TM.

[tradermichael] 30/11/2018 10:32

I'll surrender a few at 1610p ….. ;0)

[glasgow13] 30/11/2018 10:30

Is it time to take some profit?

[tradermichael] 30/11/2018 10:25

Swing time ….. ;0)

[sicker] 29/11/2018 15:53

short answer----no

[alphorn] 29/11/2018 11:56

Maybe that the price being asked is too high? Hence only one bidder left at the table.

(fwiw. Extended my long position in GSK just now).

[fangorn2] 29/11/2018 11:53

"In response to recent press speculation, GSK confirms that consideration is being given to a potential transaction that includes a merger of GSKCH."

Outright sale preferred surely?

[porsche1945] 29/11/2018 11:27

This usually gets a nose bleed and altitude sickness around 16...it needs to rise strongly through 16 plus and hold to maintain, questionable what catylysts beyond horlicks to hold it up tho, a surprise higher price for Hor’ might do it.

[ny boy] 29/11/2018 11:16

Trader Michael

1620p is resistance if we get through that level, I am expecting 1702p ish but there could be flip flops along the way, I am just holding as the quarterly divi is still attractive

Good steady progress so far GL

[warranty] 28/11/2018 20:25

I would think it's fair to say TM that at this point the price will already have been agreed and there are just the legal and other arrangements to agree and implement. Hopefully the price is at or above that speculated, it's certainly a valuable and growing product in the Indian market so shouldn't go cheap. Fingers crossed for a good reaction when revealed.

[tradermichael] 28/11/2018 13:42

The way the market has been reacting to very positive GSK news lately, it will be said that the sale was 'already in the price'. What could impact is if they achieve a price significantly in excess of 'expectations', e.g. >$4 billion, or no sale at all.

[jadeticl3] 28/11/2018 13:20

Are these sales of Horlick already factored into the share price or should we expect some positive movement once tha sales become a reality?

[billionairepaddy] 28/11/2018 13:05

tks for info traderm

[tradermichael] 28/11/2018 12:54

This particular sale is the India Horlicks Division (Horlicks and Boost), where GSK owns a 72.5% stake.

However, in July last year, Glaxo reported that it planned to sell its Horlicks malt drink brand in the UK, resulting in more than 300 job cuts.
The firm said it would offload the business in the UK and close the site in Slough, England where the malted drink is made as part of plans to focus on its core drugs division.

[billionairepaddy] 28/11/2018 12:45

is offer for all of Horlicks or just the india section